The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage ...

Hardware teams are hitting bottlenecks as custom-part sourcing grows slower and costlier. Here’s why it’s breaking workflows.

Novartis ($NVS) is reportedly in talks with Merck & Co. ($MRK) to trade its vaccines and animal health businesses for Merck & Co.'s consumer health operations. If ...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments ...

Blue Bird’s third quarter was characterized by robust revenue growth and margin expansion, prompting a positive market reaction. Management attributed the performance to disciplined pricing, ...

Erik Kaufman, The Daily Republic, Mitchell, S.D. Oct. 6—MITCHELL — Ed Thompson stands in front of a couple dozen sixth-grade students at Mitchell Middle School and tries to answer all the curious ...

Stratasys’ third quarter results met Wall Street’s revenue expectations, but the market reacted negatively as year-over-year sales declined and margin pressures persisted. Management attributed the ...